The restructuring involved a common stock consolidation that took effect Nov. 24, 2010. The stock symbol for Solos will be changed temporarily to SNDYD for a period of 20 business days following the consolidation.
The plan will allow Solos greater flexibility to use the assets of the company for corporate purposes, including raising capital, acquisitions or employee compensation.
Read the Solos Endoscopy news release on capital restructuring.
Read more on GI and endoscopy:
–4 Steps to Increase Screening Colonoscopy Cases
–Researchers Revisit Surveillance Colonoscopy Utilization
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
